Recent studies of tumors such as breast cancers [39]–[41] and lymphomas [42] have shown that increased expression of APOBEC3B in vivo was linked to the chronic induction of mutations and/or instability in genomic DNA. This evidence concerns the gene APOBEC3B and breast carcinoma.